Cargando…
The suppression effects of desacetyluvaricin on hepatocellular carcinoma and its possible mechanism
OBJECTIVE: To investigate the anticancer effects of desacetyluvaricin (DES) on hepatocellular carcinoma (HCC) in vitro, and to study its mechanism. MATERIALS AND METHODS: Using DES and cisplatin (DDP) to intervene the cell lines of hepatocarcinoma G2.2.15 (HepG2.2.15) and HepG2, by detecting the exp...
Autores principales: | Yu, Jian Zhong, Wu, Xian-Lin, Yu, Bin, Dai, Cong-qi, Liu, Kang-Li, Guo-Qiang, Qian, Zhou, Guang X., Lu, Su H., Ju, Da H., Chen, Xiao Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3466458/ https://www.ncbi.nlm.nih.gov/pubmed/23060697 http://dx.doi.org/10.4103/0973-1296.99288 |
Ejemplares similares
-
The effect of desacetyluvaricin on the expression of TLR4 and P53 protein in Hepg 2.2.15
por: He, Hai Bin, et al.
Publicado: (2011) -
Identification of key genes and important histone modifications in hepatocellular carcinoma
por: Liu, Yu-Xian, et al.
Publicado: (2020) -
FABP4 suppresses proliferation and invasion of hepatocellular carcinoma cells and predicts a poor prognosis for hepatocellular carcinoma
por: Zhong, Cheng‐Qian, et al.
Publicado: (2018) -
Exploring the Mechanism of Flaccidoxide-13-Acetate in Suppressing Cell Metastasis of Hepatocellular Carcinoma
por: Wu, Yu-Jen, et al.
Publicado: (2020) -
Modified AS1411 Aptamer Suppresses Hepatocellular Carcinoma by Up-Regulating Galectin-14
por: Cho, Yuri, et al.
Publicado: (2016)